Pacira BioSciences
$22.6
23
-$0.67-2.88% Tuesday 20:00
Statistics
Day High
23.61
Day Low
22.32
52W High
27.64
52W Low
18.8
Volume
498,731
Avg. Volume
913,126
Mkt Cap
915.07M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
6MayExpected
Expected EPS
0.577143
Actual EPS
N/A
Financials
0.97%Profit Margin
Profitable1.45BRevenue
14.07MNet Income
Analyst Ratings
$30.25Average Price Target
The highest estimate is 38.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy 75%
Hold 25%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PCRX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Abbvie
ABBV
Mkt Cap385.18B
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
AMGEN
AMGN
Mkt Cap160.66B
Merck
MRK
Mkt Cap214.76B
Novartis
NVS
Mkt Cap237.61B
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
About
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Show more...
CEO
Mr. Frank D. Lee
Employees
788
Country
US
ISIN
US6951271005
Listings
0 Comments
Share your thoughts
FAQ
What is Pacira BioSciences stock price today?▼
The current price of PCRX is $22.6 USD — it has decreased by -2.88% in the past 24 hours. Watch Pacira BioSciences stock price performance more closely on the chart.
What is Pacira BioSciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pacira BioSciences stocks are traded under the ticker PCRX.
Is Pacira BioSciences stock price growing?▼
PCRX stock has fallen by -3.79% compared to the previous week, the month change is a +3.15% rise, over the last year Pacira BioSciences has showed a -6.11% decrease.
What is Pacira BioSciences market cap?▼
Today Pacira BioSciences has the market capitalization of 915.07M
When is the next Pacira BioSciences earnings date?▼
Pacira BioSciences is going to release the next earnings report on May 06, 2026.
What were Pacira BioSciences earnings last quarter?▼
PCRX earnings for the last quarter are 0.57 USD per share, whereas the estimation was 0.9 USD resulting in a -37.01% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Pacira BioSciences revenue for the last year?▼
Pacira BioSciences revenue for the last year amounts to 1.45B USD.
What is Pacira BioSciences net income for the last year?▼
PCRX net income for the last year is 14.07M USD.
How many employees does Pacira BioSciences have?▼
As of April 01, 2026, the company has 788 employees.
In which sector is Pacira BioSciences located?▼
Pacira BioSciences operates in the Health Care sector.
When did Pacira BioSciences complete a stock split?▼
Pacira BioSciences has not had any recent stock splits.
Where is Pacira BioSciences headquartered?▼
Pacira BioSciences is headquartered in Tampa, US.